0,827  0,004  Caspase 3 stimulant
0,828  0,006  Antineoplastic (lung cancer)
0,829  0,007  Caspase 9 stimulant
0,788  0,004  Tubulin antagonist
0,760  0,013  Antineoplastic (breast cancer)
0,764  0,021  Apoptosis agonist
0,739  0,007  Prostate cancer treatment
0,705  0,005  Antineoplastic (carcinoma)
0,695  0,004  Antineoplastic (squamous cell carcinoma)
0,681  0,005  Antimitotic
0,691  0,015  Antineoplastic (colorectal cancer)
0,666  0,005  Antineoplastic (multiple myeloma)
0,675  0,015  Antineoplastic (colon cancer)
0,655  0,004  Hepatoprotectant
0,653  0,009  Antineoplastic (melanoma)
0,648  0,005  CYP2C19 inhibitor
0,645  0,008  Hepatic disorders treatment
0,638  0,007  Antineoplastic (brain cancer)
0,618  0,013  5 Hydroxytryptamine release stimulant
0,605  0,008  Antineoplastic (glioma)
0,606  0,010  Antineoplastic (non-small cell lung cancer)
0,608  0,016  Antihypercholesterolemic
0,596  0,005  Antineoplastic (glioblastoma multiforme)
0,596  0,011  Antineoplastic (pancreatic cancer)
0,582  0,003  Alpha tubulin antagonist
0,553  0,006  Antineoplastic (renal cancer)
0,559  0,013  NOS2 expression inhibitor
0,552  0,017  Antineoplastic (cervical cancer)
0,537  0,005  Liver fibrosis treatment
0,518  0,010  Antineoplastic (lymphoma)
0,530  0,023  Antineoplastic (ovarian cancer)
0,537  0,033  Antileukemic
0,512  0,014  Antipyretic
0,506  0,008  P-glycoprotein inhibitor
0,464  0,004  Beta tubulin antagonist
0,497  0,041  CYP3A4 substrate
0,460  0,014  Sigma receptor agonist
0,436  0,011  Muscle relaxant
0,433  0,024  CYP3A4 inhibitor
0,432  0,028  CYP2D6 inhibitor
0,417  0,016  Antineoplastic (lymphocytic leukemia)
0,434  0,034  Spasmolytic
0,446  0,052  Histamine release inhibitor
0,394  0,010  Skeletal muscle relaxant
0,402  0,018  RNA-directed DNA polymerase inhibitor
0,430  0,053  CYP2C9 substrate
0,379  0,007  Neurotrophic factor enhancer
0,400  0,029  DNA damaging
0,388  0,022  Antineoplastic (small cell lung cancer)
0,393  0,029  Chemopreventive
0,384  0,025  Psychostimulant
0,377  0,019  Antiparkinsonian, rigidity relieving
0,384  0,026  Antineoplastic (liver cancer)
0,395  0,037  Vasodilator, coronary
0,407  0,053  Vasodilator, peripheral
0,362  0,009  Acetylcholinesterase inhibitor
0,365  0,012  Topoisomerase II inhibitor
0,412  0,061  Transcription factor NF kappa B inhibitor
0,369  0,022  Abortion inducer
0,368  0,029  Vasodilator
0,373  0,037  Sensitization
0,418  0,095  Antineoplastic (solid tumors)
0,358  0,035  Cardiodepressant
0,329  0,015  Cholinergic
0,315  0,009  CDC-like kinase 1 inhibitor
0,339  0,033  Nitric oxide antagonist
0,349  0,045  Hypoxia-inducible factor 1 alpha inhibitor
0,313  0,010  Topoisomerase I inhibitor
0,385  0,083  TNF expression inhibitor
0,318  0,029  Anesthetic general
0,337  0,050  Antioxidant
0,292  0,011  Carcinogenic, group 1
0,334  0,061  Calcium channel activator
0,326  0,059  Lipoxygenase inhibitor
0,292  0,026  Male reproductive disfunction treatment
0,273  0,013  Butyrylcholinesterase inhibitor
0,331  0,072  ICAM1 expression inhibitor
0,324  0,065  Respiratory analeptic
0,301  0,043  DNA synthesis inhibitor
0,299  0,042  Cyclic AMP phosphodiesterase inhibitor
0,257  0,004  Antineoplastic alkaloid
0,256  0,007  Microtubule formation inhibitor
0,271  0,023  Lipid peroxidase inhibitor
0,249  0,004  CDC-like kinase 3 inhibitor
0,301  0,059  CYP1A2 inhibitor
0,268  0,027  Acaricide
0,267  0,026  Melanin inhibitor
0,333  0,092  CYP2C9 inhibitor
0,265  0,034  Pneumotoxic
0,266  0,038  VCAM1 expression inhibitor
0,251  0,024  Erectile dysfunction treatment
0,334  0,109  15-Lipoxygenase inhibitor
0,235  0,017  Phobic disorders treatment
0,235  0,018  ATPase inhibitor
0,297  0,081  12-Lipoxygenase inhibitor
0,236  0,028  LDLR expression enhancer
0,266  0,058  5 Hydroxytryptamine 1E antagonist
0,228  0,021  Antiviral (Hepatitis B)
0,271  0,073  GST M1-1 substrate
0,289  0,093  Apoptosis antagonist
0,211  0,015  Cyclooxygenase 3 inhibitor
0,258  0,064  Cytostatic
0,213  0,021  Alpha 2b adrenoreceptor antagonist
0,191  0,004  Endothelin receptor antagonist
0,266  0,083  CYP2C19 substrate
0,201  0,018  Alpha 2c adrenoreceptor antagonist
0,185  0,005  Phosphodiesterase 11A inhibitor
0,185  0,005  Phosphodiesterase XI inhibitor
0,266  0,087  CYP1A2 substrate
0,248  0,069  Free radical scavenger
0,252  0,075  Proliferative diseases treatment
0,216  0,039  Amylase inhibitor
0,186  0,010  Inducible nitric-oxide synthase inhibitor
0,238  0,062  Antihypertriglyceridemic
0,289  0,114  Ulceration
0,202  0,031  Antifungal enhancer
0,222  0,052  CYP2B6 inhibitor
0,254  0,087  UGT2B4 substrate
0,243  0,077  Cardiovascular analeptic
0,225  0,059  Antiviral (Influenza)
0,201  0,036  UGT2B10 substrate
0,267  0,104  Bone diseases treatment
0,248  0,085  Transcription factor STAT3 inhibitor
0,200  0,038  Heat shock protein 90 antagonist
0,172  0,010  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,261  0,099  Analeptic
0,239  0,079  Tyrosine 3 hydroxylase inhibitor
0,195  0,038  Genotoxic
0,219  0,063  Sedative
0,177  0,021  Alpha 2 adrenoreceptor antagonist
0,172  0,017  Multidrug resistance-associated protein 1 inhibitor
0,153  0,004  Endothelin A receptor antagonist
0,204  0,056  5 Hydroxytryptamine 3E antagonist
0,193  0,045  Antineoplastic (bone cancer)
0,211  0,064  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,184  0,039  NADPH oxidase inhibitor
0,268  0,123  Antiprotozoal (Plasmodium)
0,170  0,026  Pregnane X receptor agonist
0,303  0,164  Alzheimer's disease treatment
0,157  0,022  Topoisomerase II alpha inhibitor
0,256  0,121  Cholesterol antagonist
0,146  0,011  Phosphodiesterase V inhibitor
0,137  0,004  Endothelin B receptor antagonist
0,202  0,069  Carcinogenic
0,185  0,054  Antiviral (Herpes)
0,232  0,102  Antiosteoporotic
0,179  0,050  Contraceptive
0,139  0,010  ATPase (Vacuolar H+) inhibitor
0,153  0,026  Antiviral (Influenza B)
0,264  0,138  Immunosuppressant
0,139  0,014  Restless leg syndrome treatment
0,178  0,055  Antiviral (Influenza A)
0,226  0,103  Antineoplastic (bladder cancer)
0,183  0,062  3C-like protease (Human coronavirus) inhibitor
0,144  0,024  Carcinogenic, group 2A
0,145  0,025  Breast cancer-resistant protein inhibitor
0,275  0,155  Antibacterial
0,143  0,026  Nitric-oxide synthase inhibitor
0,175  0,059  Arachidonic acid antagonist
0,122  0,006  Heat shock protein 90 beta antagonist
0,232  0,116  CYP2D6 substrate
0,196  0,082  Clk dual-specificity kinase inhibitor
0,148  0,034  Choleretic
0,141  0,027  DOPA decarboxylase inhibitor
0,216  0,104  Antineoplastic (sarcoma)
0,138  0,026  Calcium antagonist
0,127  0,016  Phosphodiesterase 5A inhibitor
0,114  0,005  Glutamate (mGluR7) antagonist
0,165  0,057  Raynaud's phenomenon treatment
0,174  0,067  Heat shock protein 90 alpha antagonist
0,260  0,154  Antiprotozoal
0,221  0,118  Gastrin inhibitor
0,143  0,041  Papain-like protease (SARS coronavirus) inhibitor
0,204  0,102  Antihypotensive
0,167  0,065  Uterine stimulant
0,104  0,004  Ryanodine receptor antagonist
0,133  0,033  5 Hydroxytryptamine 2A antagonist
0,145  0,046  5 Hydroxytryptamine 2 antagonist
0,118  0,020  Dopamine D1 antagonist
0,143  0,046  DNA intercalator
0,156  0,059  Anesthetic
0,106  0,012  Antitreponemal
0,148  0,055  Antiseptic
0,216  0,123  5 Hydroxytryptamine uptake stimulant
0,227  0,135  CTGF expression inhibitor
0,179  0,087  Cytotoxic
0,156  0,069  Acetylcholine M1 receptor antagonist
0,103  0,017  Postmenopausal disorders treatment
0,136  0,049  Antiviral (Papilloma)
0,138  0,052  Antitussive
0,148  0,067  Adenylate cyclase stimulant
0,261  0,181  Alpha-glucosidase inhibitor
0,172  0,093  Amyloid beta aggregation inhibitor
0,117  0,038  UGT2B11 substrate
0,165  0,086  Antipruritic, non-allergic
0,152  0,075  UGT2B9 substrate
0,099  0,025  Dopamine D3 antagonist
0,081  0,008  Adenylate cyclase 1 inhibitor
0,103  0,031  Histidine decarboxylase inhibitor
0,143  0,071  Antiparkinsonian, tremor relieving
0,227  0,156  FMO1 substrate
0,115  0,044  Anabolic
0,101  0,032  mTOR complex 2 inhibitor
0,161  0,094  Platelet adhesion inhibitor
0,213  0,148  AR expression inhibitor
0,268  0,203  5 Hydroxytryptamine release inhibitor
0,130  0,067  Vanilloid 1 agonist
0,099  0,039  Contraceptive male
0,118  0,059  Estrogen antagonist
0,098  0,039  Antiviral (Hepatitis A)
0,091  0,033  CDC25A inhibitor
0,161  0,103  Non-steroidal antiinflammatory agent
0,138  0,081  Ca2+-transporting ATPase inhibitor
0,193  0,138  UGT1A9 substrate
0,111  0,057  Antiprotozoal (Toxoplasma)
0,088  0,037  5 Hydroxytryptamine 1A antagonist
0,098  0,047  Antineoplastic antibiotic
0,065  0,014  Factor III inhibitor
0,065  0,014  Estrogen receptor alpha agonist
0,118  0,068  Antifungal (Pneumocystis)
0,091  0,041  Glycine receptor antagonist
0,099  0,050  SULT1E1 substrate
0,135  0,089  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,117  0,071  Alcohol dehydrogenase substrate
0,087  0,041  Keratolytic
0,168  0,124  Antineoplastic enhancer
0,075  0,032  SULT2A1 substrate
0,105  0,063  Antihypermotility
0,086  0,044  Dopamine antagonist
0,062  0,020  Topoisomerase II beta inhibitor
0,072  0,031  Protease activated receptor antagonist
0,080  0,040  Dopamine D2 antagonist
0,110  0,070  5 Hydroxytryptamine antagonist
0,066  0,026  Postcoital contraceptive
0,171  0,133  Tumour necrosis factor alpha release inhibitor
0,096  0,059  Alpha adrenoreceptor antagonist
0,070  0,033  Antiviral (Parainfluenza)
0,059  0,022  Potassium channel Kv1.3 blocker
0,234  0,198  Transcription factor inhibitor
0,073  0,037  Exportin-1 inhibitor
0,158  0,123  Antiparasitic
0,132  0,097  Mutagenic
0,102  0,067  Expectorant
0,108  0,073  Interleukin 1b antagonist
0,099  0,066  Estrogen receptor beta antagonist
0,070  0,037  5 Hydroxytryptamine 2A agonist
0,102  0,070  GST T1-1 substrate
0,076  0,044  Calcium channel L-type blocker
0,110  0,078  Alkylator
0,127  0,096  Antiprotozoal (Coccidial)
0,040  0,009  Dopamine autoreceptor agonist
0,098  0,068  Carcinogenic, group 2B
0,161  0,132  Antiprotozoal (Leishmania)
0,058  0,029  Nicotinic alpha3beta2 receptor antagonist
0,079  0,050  Estrogen receptor alpha antagonist
0,050  0,022  Phosphodiesterase 6C inhibitor
0,076  0,049  5 Hydroxytryptamine 1 antagonist
0,055  0,029  Anesthetic inhalation
0,069  0,044  Female sexual dysfunction treatment
0,074  0,050  Glutamate decarboxylase inhibitor
0,145  0,122  Succinate dehydrogenase inhibitor
0,132  0,110  Heat shock protein 70 antagonist
0,118  0,095  Protein kinase stimulant
0,075  0,054  GABA B receptor agonist
0,083  0,063  Transcription factor NF kappa B stimulant
0,157  0,137  Platelet antagonist
0,109  0,090  Contraceptive female
0,144  0,125  Antiviral (Hepatitis)
0,183  0,164  Antifungal
0,102  0,083  Acetylcholine release stimulant
0,102  0,084  Carcinogenic, group 3
0,101  0,083  Activin receptor-like kinase 4 inhibitor
0,052  0,035  5 Hydroxytryptamine 4 antagonist
0,033  0,017  Phosphodiesterase 6B inhibitor
0,051  0,036  5 Hydroxytryptamine 2 agonist
0,104  0,089  Sphingosine 1-phosphate receptor 2 agonist
0,124  0,109  UGT2B7 substrate
0,023  0,009  Progesterone receptor B antagonist
0,139  0,125  Pyruvate kinase inhibitor
0,147  0,133  Antirickettsial
0,070  0,057  Alpha 2a adrenoreceptor antagonist
0,090  0,076  Phosphodiesterase 6D inhibitor
0,107  0,094  Antiprotozoal (Amoeba)
0,066  0,053  Elastase 1 inhibitor
0,214  0,201  Antineoplastic (non-Hodgkin's lymphoma)
0,100  0,089  Photosensitizer
0,024  0,015  Phosphodiesterase 6G inhibitor
0,024  0,015  Phosphodiesterase 6H inhibitor
0,056  0,047  Lipocortins synthesis agonist
0,146  0,139  Insulin sensitizer
0,067  0,060  Acetylcholine M4 receptor antagonist
0,033  0,026  Tubulin agonist
0,166  0,159  Radioprotector
0,044  0,039  Estrogen agonist
0,177  0,172  Transcription factor STAT inhibitor
0,095  0,090  5 Hydroxytryptamine 2B antagonist
0,119  0,115  Hemostatic
0,125  0,122  Interferon gamma antagonist
0,068  0,065  Nicotinic alpha4beta2 receptor antagonist
0,141  0,138  Toxic, respiratory center
0,134  0,131  Antineoplastic (gastric cancer)
0,026  0,024  Nicotinic alpha4beta2 receptor agonist
0,092  0,090  Mucolytic
0,054  0,052  Alpha 2 adrenoreceptor agonist
0,044  0,042  Carnitine palmitoyltransferase 1B inhibitor
0,049  0,047  Alpha-mannosidase inhibitor
0,018  0,018  Imidazoline I1 receptor antagonist
0,045  0,045  Prolyl endopeptidase inhibitor
0,092  0,091  Anesthetic local

